ALVOW Company Profile and Key Details

NASDAQ : ALVOW

Alvotech

$0.33

-0.0201-6.09%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Alvotech (ALVOW) stock declined over -6.09%, trading at $0.33 on NASDAQ, down from the previous close of $0.33. The stock opened at $0.31, fluctuating between $0.31 and $0.33 in the recent session.

Stock Snapshot

0.3301

Prev. Close

103.07M

Market Cap

0.31

Day Low

N/A

P/E Ratio

N/A

EPS (TTM)

-1.34

Cash Flow per Share

0.31

Open

312.24M

Number of Shares

0.3301

Day High

36.1%

Free Float in %

-3.49

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 30, 2026	0.31	0.31	0.31	0.31	500
Mar 27, 2026	0.20	0.20	0.20	0.20	37
Mar 24, 2026	0.24	0.25	0.19	0.23	9.81K
Mar 23, 2026	0.25	0.25	0.25	0.25	3.14K
Mar 20, 2026	0.25	0.25	0.25	0.25	2.22K
Mar 17, 2026	0.30	0.33	0.30	0.33	2.93K
Mar 16, 2026	0.33	0.33	0.30	0.30	2.46K
Mar 12, 2026	0.32	0.32	0.32	0.32	51
Mar 11, 2026	0.33	0.33	0.33	0.33	140
Mar 09, 2026	0.33	0.33	0.33	0.33	400
Mar 06, 2026	0.37	0.37	0.37	0.37	510
Mar 03, 2026	0.38	0.43	0.25	0.30	7.76K
Mar 02, 2026	0.56	0.56	0.39	0.39	904
Feb 26, 2026	0.50	0.50	0.37	0.40	9.88K
Feb 25, 2026	0.28	0.35	0.28	0.35	16.97K
Feb 24, 2026	0.28	0.28	0.28	0.28	2.76K
Feb 23, 2026	0.19	0.28	0.19	0.28	1.95K
Feb 20, 2026	0.28	0.29	0.16	0.16	1.7K
Feb 19, 2026	0.30	0.31	0.15	0.30	6.54K
Feb 18, 2026	0.31	0.31	0.30	0.30	2.68K

Contact Details

Luxembourg, 102

Iceland

https://www.alvotech.com 354 422 4500

About Company

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 NBIX

-0.96-0.72%

Neurocrine Biosciences, Inc.$131.60 LNTH

0.4+0.53%

Lantheus Holdings, Inc.$76.10 ANIP

-1.75-2.30%

ANI Pharmaceuticals, Inc.$74.21 PAHC

0.76+1.39%

Phibro Animal Health Corporation$55.52 SUPN

-0.96-1.87%

Supernus Pharmaceuticals, Inc.$50.48 HROW

-0.12-0.34%

Harrow Health, Inc.$35.31 COLL

-0.94-2.83%

Collegium Pharmaceutical, Inc.$32.31 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98 RGC

-2.92-8.66%

Regencell Bioscience Holdings Limited$30.80

Company Overview

The stock is currently mid-range between its 52-week high and low $0.20 and $1.98. With a market capitalization of about $103.07 million, Alvotech is classified as a micro-cap and shows lower-than-market volatility (beta ~0.25). Key stats such as the average daily volume over the past year has been around 5.34 thousand shares, volume is running light vs its 52-week average. Headquartered in Luxembourg, None, Alvotech operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Vilhelm Robert Wessman, the company employs approximately 1,012 people and listed since June 16, 2022. Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets.

Technical Performance

ALVOW has shown sold momentum, gaining 7.49% over the past week and 250.17% over the past quarter, though year-to-date performance is up 221.12%. Average 10-day trading volume of 268.50 shares is below the 3-month average of 3.25 thousand, indicating normal recent market interest.

Valuation Metrics

Alvotech trades at a P/E ratio of 36.5, slightly above the S&P 500 average, with a price-to-sales ratio of 1.94 and a price-to-book ratio of -3.58 indicating negative book value, which may reflect financial stress. The P/FCF stands at -9.92, also below market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Earnings & Analyst Outlook

Alvotech earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by 24.87%. The prior quarter beat by -330.17%. Over the last six quarters, Apple has recorded several small beats. These include -330.17% in August 13, 2025.

Financial & Profitability Overview

Over the trailing twelve months, Alvotech generated $91.43M in revenue, or $0.40 per share. Gross margin was -75.93%, operating margin -388.11%, and net profit margin -603.42%. Returns are negative, with ROA at -58.07% and ROE at 59.17%.
On valuation metrics, Alvotech trades at a P/E of 36.50, P/S of 1.94 and P/B of -3.58. The current ratio is 1.89 and quick ratio is 1.16. Operationally, the company’s inventory turnover is 1.07 and cash conversion cycle is 188.96 days. Debt-to-equity is -5.09, supported by a cash flow-to-debt ratio of -0.03.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Alvotech posted revenue of $91.43M, down slightly from $83.03M in the prior quarter. Gross profit was - $69.42M (margin -75.93%). Operating income was - $354.86M (margin -388.1%). Net income was- $551.73M (EPS - $2.43).
The company ended the quarter with $11.16M in cash and short-term investments, a total debt of $1.08B, and net debt of $1.06B. Total assets were $950.09M, with equity of - $932.49M. Financials further reflected weakness, with operating cash flow of - $312.19M, free cash flow of - $358.66M, and capital expenditures of - $46.47M.

Price Forecast & Outlook

Our AI price prediction model suggests that Alvotech stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 441.94%, with price expected at $1.68 by November 24, 2023, within a range of $1.48 to $1.90

Key Takeaways

Alvotech (NASDAQ:ALVOW) shares are up 221.12% year-to-date Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Alvotech trading at a premium to the broader market with a P/E of 36.5.

Frequently Asked Questions

What is the current Alvotech (ALVOW) stock price?

Alvotech (NASDAQ: ALVOW) stock price is $0.33 in the last trading session. During the trading session, ALVOW stock reached the peak price of $0.33 while $0.31 was the lowest point it dropped to. The percentage change in ALVOW stock occurred in the recent session was -6.09% while the dollar amount for the price change in ALVOW stock was - $0.02.

ALVOW's industry and sector of operation?

The NASDAQ listed ALVOW is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Alvotech designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALVOW?

No Data

How ALVOW did perform over past 52-week?

ALVOW's closing price is 65.05% higher than its 52-week low of $0.20 where as its distance from 52-week high of $1.98 is -83.33%.

How many employees does ALVOW have?

Number of ALVOW employees currently stands at 1,012.

Link for ALVOW official website?

Official Website of ALVOW is: https://www.alvotech.com

How do I contact ALVOW?

ALVOW could be contacted at phone 354 422 4500 and can also be accessed through its website. ALVOW operates from Saemundargata 15-19, Luxembourg, 102, Iceland.

How many shares of ALVOW are traded daily?

ALVOW stock volume for the day was 37 shares. The average number of ALVOW shares traded daily for last 3 months was 5.34K.

What is the market cap of ALVOW currently?

The market value of ALVOW currently stands at $103.07M with its latest stock price at $0.33 and 312.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1012
Beta	0.25
Sales or Revenue	$91.43M
5Y Sales Change%	2.071%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

ALVOW Company Profile and Key Details

Alvotech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook